{"id":36693,"date":"2025-12-01T10:44:36","date_gmt":"2025-12-01T09:44:36","guid":{"rendered":"https:\/\/ggba.swiss\/?p=36693"},"modified":"2025-12-02T08:43:34","modified_gmt":"2025-12-02T07:43:34","slug":"takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/","title":{"rendered":"Takeda inaugurates CHF 200 million biotechnology facility in Neuch\u00e2tel"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.takeda.com\/\">Takeda<\/a> has inaugurated a new biotechnology facility in Neuch\u00e2tel following an investment of CHF 200 million, the largest ever made at the site. The inauguration ceremony brought together representatives from Switzerland and Japan, including Federal Councillor Guy Parmelin, Toshiro Iijima, Japan\u2019s Ambassador-designate to Switzerland, and Florence Nater, Neuch\u00e2tel State Councillor. Senior Takeda leadership, including Global Manufacturing &amp; Supply Officer Thomas Wozniewski and Neuch\u00e2tel Site Head S\u00e9bastien Bourgeois, also attended the event.<\/p>\n\n\n\n<p>Located in the Pierre-\u00e0-Bot industrial area above the city, Takeda\u2019s Neuch\u00e2tel site is already one of the canton\u2019s largest employers, with more than 650 employees of over 20 nationalities. The facility plays a central role in the group\u2019s global manufacturing network, producing recombinant therapies supplied to more than 70 markets. This latest investment builds on Takeda\u2019s earlier expansion plans and reflects the strategic importance of Neuch\u00e2tel as a long-term production base.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">A state-of-the-art aseptic filling plant<\/h4>\n\n\n\n<p>The new facility integrates multiple processes essential to sterile biologics production, including formulation, aseptic filling, freeze-drying, sealing and automated quality control. Designed as a highly digitalized \u201cfactory of the future,\u201d the site incorporates advanced automation systems intended to increase reliability, throughput and traceability while reducing manual handling.<\/p>\n\n\n\n<p>According to Takeda, the infrastructure will support the company\u2019s objective of improving access to life-changing treatments for patients with rare diseases in more than 80 countries. \u201cThanks to this new infrastructure, we can treat more patients while contributing to the economic and industrial development of the region,\u201d said Thomas Wozniewski.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Strengthening Neuch\u00e2tel\u2019s life sciences ecosystem<\/h4>\n\n\n\n<p>The expansion consolidates Neuch\u00e2tel\u2019s position as a leading hub for advanced biomanufacturing in Western Switzerland, a region known for its concentration of precision industries, medtech expertise and research institutions such as <a href=\"https:\/\/www.csem.ch\/en\/\">CSEM<\/a>, <a href=\"https:\/\/www.microcity.ch\/\">Microcity<\/a> and the <a href=\"https:\/\/www.unine.ch\/\">University of Neuch\u00e2tel<\/a>. Takeda also collaborates closely with cantonal authorities, academic partners and vocational training initiatives, further embedding the site within the local innovation ecosystem.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.<\/p>\n","protected":false},"author":6,"featured_media":36745,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[943,912,890,1011,918,929,911],"class_list":["post-36693","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-advanced-manufacturing","tag-biotech","tag-healthcare","tag-infrastructures","tag-investment","tag-manufacturing","tag-pharma"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Takeda inaugurates CHF 200 million biotechnology facility | GGBa<\/title>\n<meta name=\"description\" content=\"Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeda inaugurates CHF 200 million biotechnology facility | GGBa\" \/>\n<meta property=\"og:description\" content=\"Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-01T09:44:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T07:43:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Takeda inaugurates CHF 200 million biotechnology facility in Neuch\u00e2tel\",\"datePublished\":\"2025-12-01T09:44:36+00:00\",\"dateModified\":\"2025-12-02T07:43:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\"},\"wordCount\":331,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg\",\"keywords\":[\"Advanced Manufacturing\",\"Biotech\",\"Healthcare\",\"Infrastructures\",\"Investment\",\"Manufacturing\",\"Pharma\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\",\"url\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\",\"name\":\"Takeda inaugurates CHF 200 million biotechnology facility | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg\",\"datePublished\":\"2025-12-01T09:44:36+00:00\",\"dateModified\":\"2025-12-02T07:43:34+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg\",\"width\":1180,\"height\":811,\"caption\":\"From left to right: Thomas Wozniewski (Global Manufacturing and Supply Officer at Takeda), H.E. Toshiro Iijima (Japan's Ambassador-designate to Switzerland), Guy Parmelin (Federal Councilor, EAER), Florence Nater (Neuch\u00e2tel State Councilor, Head of the Department of Economic Affairs and Social Cohesion) and Sebastien Bourgeois (Site Head Neuch\u00e2tel at Takeda) inaugurate the biotechnology facility in Neuch\u00e2tel. | \u00a9 Takeda\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Takeda inaugurates CHF 200 million biotechnology facility in Neuch\u00e2tel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Takeda inaugurates CHF 200 million biotechnology facility | GGBa","description":"Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/","og_locale":"en_US","og_type":"article","og_title":"Takeda inaugurates CHF 200 million biotechnology facility | GGBa","og_description":"Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.","og_url":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-12-01T09:44:36+00:00","article_modified_time":"2025-12-02T07:43:34+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Takeda inaugurates CHF 200 million biotechnology facility in Neuch\u00e2tel","datePublished":"2025-12-01T09:44:36+00:00","dateModified":"2025-12-02T07:43:34+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/"},"wordCount":331,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg","keywords":["Advanced Manufacturing","Biotech","Healthcare","Infrastructures","Investment","Manufacturing","Pharma"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/","url":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/","name":"Takeda inaugurates CHF 200 million biotechnology facility | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg","datePublished":"2025-12-01T09:44:36+00:00","dateModified":"2025-12-02T07:43:34+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Takeda has opened a new CHF 200 million biotechnology facility in Neuch\u00e2tel to expand aseptic filling capacity for rare disease therapies.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/12\/Takeda-Inauguration-Neuchatel.jpg","width":1180,"height":811,"caption":"From left to right: Thomas Wozniewski (Global Manufacturing and Supply Officer at Takeda), H.E. Toshiro Iijima (Japan's Ambassador-designate to Switzerland), Guy Parmelin (Federal Councilor, EAER), Florence Nater (Neuch\u00e2tel State Councilor, Head of the Department of Economic Affairs and Social Cohesion) and Sebastien Bourgeois (Site Head Neuch\u00e2tel at Takeda) inaugurate the biotechnology facility in Neuch\u00e2tel. | \u00a9 Takeda"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/takeda-inaugurates-chf-200-million-biotechnology-facility-in-neuchatel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Takeda inaugurates CHF 200 million biotechnology facility in Neuch\u00e2tel"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/36693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=36693"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/36693\/revisions"}],"predecessor-version":[{"id":36697,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/36693\/revisions\/36697"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/36745"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=36693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=36693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=36693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}